Medifast (NYSE: MED) reported Q4 EPS of $0.10, $0.24 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $119 million versus the consensus estimate of $131.65 million.

GUIDANCE:

Medifast sees Q1 2025 revenue of $100-120 million, versus the consensus of $130.75 million.

For earnings history and earnings-related data on Medifast (MED) click here.